Skip to content
OpenCapital
Get started

Clorox CLX Derivative instruments subject to contractually defined counterparty liability position limits

Other financials

Income statement

See full
Revenue$1.7B+0.1%
Gross profit$722.0M-3.0%
Net income$187.0M+0.5%
EPS (diluted)$1.54+2.7%

Balance sheet

See full
Cash & equivalents$1.2B+418%
Total debt$4.5B+52.4%
Total equity-$67.0M-348%
Total assets$6.4B+16.8%

Cash flow

See full
Operating cash flow$311.0M+72.8%
CapEx$43.0M-18.9%
Free cash flow$269.0M+112%

Valuation

See full
Market cap$11.58B-30.9%
Enterprise value$14.88B-24.1%
P/E15.3×-8.8×
P/S1.7×-0.7×

Profitability

See full
Gross margin43.8%-1.4pp
Net margin11.2%+1.3pp
FCF margin11.5%+1.8pp

Returns & leverage

See full
Return on equity249.6%+147pp
Debt / equity9.1×+0.1×
Current ratio0.8×+0.1×

Where this comes from

Reported directly by Clorox in its filing.

Tagged under the XBRL concept clx:DerivativeInstrumentsSubjectToContractuallyDefinedCounterpartyLiabilityPositionLimitsAmount.

The official record: Clorox’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Clorox's derivative instruments subject to contractually defined counterparty liability position limits.

Connect your AI assistant and see it in context, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Clorox's derivative instruments subject to contractually defined counterparty liability position limits?
Clorox (CLX) reported derivative instruments subject to contractually defined counterparty liability position limits of $0 in Q1 2026.